Gestational Diabetes Mellitus (GDM) in Pregnant Women

NCT05265741 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2023-04-13

No results posted yet for this study

Summary

The purpose of the trial is to discover and predict the development of GDM of pregnant women in their first trimester.

Conditions

  • Gestational Diabetes Mellitus
  • Pregnancy Complications

Sponsors & Collaborators

  • BROOKLYN INNOSEQ INC.

    collaborator UNKNOWN
  • Long Island University

    lead OTHER

Principal Investigators

  • Joseph Morin, PhD · Long Island University

  • Jeanmaire Molina, PhD · Long Island University

  • Xuebin Yin, MD · BROOKLYN INNOSEQ INC.

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-09
Primary Completion
2024-02-10
Completion
2024-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05265741 on ClinicalTrials.gov